SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?


To: scaram(o)uche who wrote (1387)9/1/1998 4:04:00 PM
From: Walter Morton  Read Replies (1) | Respond to of 2742
 
I am starting to wonder whether or not Pasteur Merieux Connaught, subsidiary of Rhone-Poulenc Group (NYSE: RP - news), has entered into a letter intent with some company other than Cistron Biotechnology, Inc. (OTC: CIST - news) to make an equity investment and to fund an Interleukin-1 beta (IL-1b) vaccine adjuvant development program.